🏋️ “A slimdown in a syringe” — Weight Watche...

Airbnb stock had its best day ever Friday… because of car rentals, luggage storage, & Gigagedon.Robinhood is IPO-ing a VC fund with Y Combinator companies… it’s super seedy (in a good way).Boxed wine sales rose 144% in the last 12 months… Luxury labels are slapping-the-bag.Plus, ...  عرض المزيد

Amazon is #1 in the Mag7 in 2026... And its Zoox pedal-less robocab is about to get its 1st fare.Just after Pringles embraced AI, Chili’s is spitting it out… Here’s what Chili’s bought instead.The biggest TV biz is hidden under Hollywood’s nose: Tubi… Fox Corp owns the Adam Sandl ...  عرض المزيد

Diabetes and obesity drugs like Ozempic, Wegovy and Mounjaro have become famous for helping users shed big amounts of weight. It's a market that could soon be worth more than $100 billion. Two companies dominate this space, Novo Nordisk which makes Ozempic and Eli Lilly, maker of ...  عرض المزيد

First there was Weight Watchers, then there was Noom, and now there’s…Wegovy? Bloomberg health reporter Emma Court helps us understand the evolution of dieting programs and where they’re going next. Later, Matthew Schnier of New York Magazine and The Cut walks us through his arti ...  عرض المزيد

WeightWatchers is going all-in on trendy new anti-obesity drugs. The gamble might save the company—if it doesn’t kill it first. By Emma Court and Ellen HuetSee omnystudio.com/listener for privacy information. 

Eli Lilly and Novo Nordisk can’t keep up with demand for their weight loss medications. In this Viewsroom podcast, Breakingviews columnists discuss the hype among celebrities, the different approaches to prescribing them in the US and Europe, and how they can reshape the world. V ...  عرض المزيد